Core Viewpoint - The company, Dongfang Biological (688298), announced that its subsidiary, Shanghai Wanzijian Biotechnology Co., Ltd., and Healgen Scientific LLC have recently obtained medical device product registration certificates in China, Australia, and Singapore, enhancing the product variety of its flow fluorescence technology platform and expanding the international market for respiratory triple detection products [1]. Group 1 - The company has received medical device product registration certificates for multiple products [1] - The registration enhances the variety of products available on the company's flow fluorescence technology platform [1] - The respiratory triple detection products will help expand the company's international market presence [1]
东方生物:子公司多款产品取得医疗器械产品注册证